204 related articles for article (PubMed ID: 14696431)
1. Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung YC; Chang YF
Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis.
Chen CC; Wang SS; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 1999 Jan; 94(1):213-8. PubMed ID: 9934758
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
[TBL] [Abstract][Full Text] [Related]
4. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
Chung YC; Chang YF
J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
Zhang GJ; Adachi I
Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer.
Yeh KY; Li YY; Hsieh LL; Lu CH; Chou WC; Liaw CC; Tang RP; Liao SK
Jpn J Clin Oncol; 2010 Jun; 40(6):580-7. PubMed ID: 20194250
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis.
Bayraktaroğlu T; Aras AS; Aydemir S; Davutoğlu C; Ustündağ Y; Atmaca H; Borazan A
Mediators Inflamm; 2004 Feb; 13(1):25-8. PubMed ID: 15203561
[TBL] [Abstract][Full Text] [Related]
12. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cytokine productions and their relationship to peritoneal sepsis and systemic inflammatory markers in patients with inflammatory bowel disease.
Yamamoto T; Umegae S; Kitagawa T; Matsumoto K
Dis Colon Rectum; 2005 May; 48(5):1005-15. PubMed ID: 15785898
[TBL] [Abstract][Full Text] [Related]
16. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
17. [Profile of selected cytokines in various forms of uveitis].
Rusiecka-Ziółkowska J; Turno-Krecicka A; Białek-Szymańska A; Salomon E
Klin Oczna; 2008; 110(7-9):269-72. PubMed ID: 19112859
[TBL] [Abstract][Full Text] [Related]
18. [Receptors of selected cytokines and angiokine bFGF in patients with colorectal cancer (a preliminary study)].
Grotowski M; Piechota W
Pol Merkur Lekarski; 2001 Nov; 11(65):398-401. PubMed ID: 11852807
[TBL] [Abstract][Full Text] [Related]
19. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
[TBL] [Abstract][Full Text] [Related]
20. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
